| 12453771 |
Methods of treating cancer using anti-CD137 antibodies |
Christopher Carl Frye, Helen KOTANIDES, Stephanie Lynn SANDEFUR |
2025-10-28 |
|
| 11512134 |
Anti-CD137 antibodies |
Christopher Carl Frye, Helen KOTANIDES, Stephanie Lynn SANDEFUR |
2022-11-29 |
$1,189,298,000 |
| 11273219 |
Toxicity management for anti-tumor activity of CARs |
Carl H. June, Bruce L. Levine, Stephan Grupp |
2022-03-15 |
|
| 11203640 |
Checkpoint inhibitor bispecific antibodies |
Yiwen Li, Dale Lincoln Ludwig, Yang Shen, Igor Edmondo Paolo D'Angelo, Gregory D. Plowman |
2021-12-21 |
$1,929,301,000 |
| 11028177 |
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells |
Jennifer Brogdon, Saar Gill, Carl H. June, Andreas Loew, John Scholler |
2021-06-08 |
$23,526,000 |
| 10906983 |
Anti-CD137 antibodies |
Christopher Carl Frye, Helen KOTANIDES, Stephanie Lynn SANDEFUR |
2021-02-02 |
$1,757,086,000 |
| 10603378 |
Toxicity management for anti-tumor activity of CARs |
Carl H. June, Bruce L. Levine, Stephan Grupp |
2020-03-31 |
|
| 9572836 |
Methods for assessing the suitability of transduced T cells for administration |
Carl H. June, Bruce L. Levine |
2017-02-21 |
|
| 9573988 |
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells |
Jennifer Brogdon, Saar Gill, Carl H. June, Andreas Loew, John Scholler |
2017-02-21 |
$8,368,000 |
| 9540445 |
Compositions and methods for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2017-01-10 |
|
| 9518123 |
Compositions and methods for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2016-12-13 |
|
| 9499629 |
Use of chimeric antigen receptor-modified T-cells to treat cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2016-11-22 |
|
| 9481728 |
Compositions and methods for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2016-11-01 |
|
| 9464140 |
Compositions and methods for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2016-10-11 |
|
| 9328156 |
Use of chimeric antigen receptor-modified T cells to treat cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2016-05-03 |
|
| 9101584 |
Methods for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2015-08-11 |
|
| 9102760 |
Compositions for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2015-08-11 |
|
| 9102761 |
Compositions for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2015-08-11 |
|
| 8975071 |
Compositions for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2015-03-10 |
|
| 8916381 |
Methods for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2014-12-23 |
|
| 8911993 |
Compositions for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2014-12-16 |
|
| 8906682 |
Methods for treatment of cancer |
Carl H. June, Bruce L. Levine, David L. Porter, Michael C. Milone |
2014-12-09 |
|
| 7939646 |
Compositions and methods for the therapy and diagnosis of prostate cancer |
Jiangchun Xu, John Stolk |
2011-05-10 |
|
| 7517952 |
Compositions and methods for the therapy and diagnosis of prostate cancer |
Jiangchun Xu, Davin C. Dillon, Jennifer Mitcham, Susan Harlocker, Yuqiu Jiang +11 more |
2009-04-14 |
|
| 7425607 |
Compositions comprising a lung tumor antigen |
Robert A. Henderson, Tongtong Wang, Yoshihiro Watanabe, Paul R. Sleath, Jeffrey C. Johnson +7 more |
2008-09-16 |
|
